Many new gene therapy treatments aren’t as profitable as predicted. But the reasons why don’t quite fit Goldman Sachs’ ...

Reports of insurance companies delaying approval of medical treatments, or outright denying them, for American patients, ...

GoodRx reports that step therapy requires patients to try lower-cost medications before coverage for prescribed treatments.

Shares of several pharmaceutical companies were higher after President Trump signed an executive order aimed at accelerating research, development and access to psychedelic medicines for the treatment ...

A triplet regimen comprising Merck’s Welireg and PD-1 blockbuster Keytruda and Eisai’s Lenvima flopped in a Phase 3 renal ...

Riverkeeper and SELC say 3 Sumter industries are releasing PFAS “forever chemicals” into the Sumter-Pocotaligo River, and ...

People who received medication-assisted treatment for opioid use at Lancaster County Prison were nearly half as likely to end ...

Angelica Vazquez claims she was "treated with hostility and exclusion" while working as a housekeeper at Jenner's Hidden ...

Range reports that with upcoming IPOs, employees must plan equity strategies to avoid hefty tax bills and financial pitfalls ...

ANKTIVA approved for patients with certain indications of non-muscle invasive bladder cancer and non-small cell lung cancer -- Commercial availability achieved within two months of announcing MENA ...

A Cochrane review finds anti-amyloid Alzheimer’s drugs offer marginal benefits amid high costs/risks. Read the full analysis ...

AnaptysBio has spun off its biopharma pipeline into First Tracks Biotherapeutics, shifting to a royalty-focused, virtual ...